Search Results - Patrick Vermersch

Refine Results
  1. 1

    Successful treatment with fingolimod of graft-versus-host disease of the central nervous system by Jordan Gauthier, Patrick Vermersch, Paul Chauvet, Pauline Varlet, Valérie Coiteux, Leonardo Magro, Ibrahim Yakoub-Agha

    Published in Blood Advances (2018-01-01)
    Get full text
    Article


  2. 2

    Long-Term Management and Therapeutic Sequencing for Patients with Relapsing Multiple Sclerosis in France: A Vignette Study by Patrick Vermersch, Xavier Moisset, Baptiste Roux, Anais Lecomte, Laura Luciani, Martine Paret, Jérôme de Sèze

    Published in Neurology and Therapy (2025-03-01)
    Get full text
    Article


  3. 3

    Artificial intelligence and science of patient input: a perspective from people with multiple sclerosis by Anne Helme, Dipak Kalra, Giampaolo Brichetto, Guy Peryer, Patrick Vermersch, Helga Weiland, Angela White, Paola Zaratin

    Published in Frontiers in Immunology (2025-02-01)
    Get full text
    Article


  4. 4

    Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative diseas... by Olivier Hermine, Laurent Gros, Truong-An Tran, Lamya Loussaief, Kathleen Flosseau, Alain Moussy, Colin D Mansfield, Patrick Vermersch

    Published in PLoS ONE (2025-01-01)
    Get full text
    Article


  5. 5

    Discovery of Novel Benzamide-Based Sigma-1 Receptor Agonists with Enhanced Selectivity and Safety by Pascal Carato, Bénédicte Oxombre, Séverine Ravez, Rajaa Boulahjar, Marion Donnier-Maréchal, Amélie Barczyk, Maxime Liberelle, Patrick Vermersch, Patricia Melnyk

    Published in Molecules (2025-09-01)
    Get full text
    Article


  6. 6

    Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis by Pierre Clavelou, Giovanni Castelnovo, Valérie Pourcher, Jerome De Sèze, Patrick Vermersch, Ali-Frederic Ben-Amor, Carine Savarin, Gilles Defer

    Published in Neurology and Therapy (2023-06-01)
    Get full text
    Article


  7. 7

    Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis by Jerome de Seze, Dominique Dive, Xavier Ayrignac, Giovanni Castelnovo, Marianne Payet, Amel Rayah, Claudio Gobbi, Patrick Vermersch, Chiara Zecca

    Published in Neurology and Therapy (2024-04-01)
    Get full text
    Article


  8. 8

    Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis by Pierre Clavelou, Giovanni Castelnovo, Valérie Pourcher, Jerome De Sèze, Patrick Vermersch, Ali-Frederic Ben-Amor, Carine Savarin, Gilles Defer

    Published in Neurology and Therapy (2023-11-01)
    Get full text
    Article


  9. 9

    Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France by Jonathan Ciron, Bertrand Bourre, Giovanni Castelnovo, Anne Marie Guennoc, Jérôme De Sèze, Ali Frederic Ben-Amor, Carine Savarin, Patrick Vermersch

    Published in Neurology and Therapy (2024-03-01)
    Get full text
    Article


  10. 10

    Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype by Bruno Brochet, Pierre Clavelou, Gilles Defer, Jérôme De Seze, Céline Louapre, Eloi Magnin, Aurélie Ruet, Catherine Thomas-Anterion, Patrick Vermersch

    Published in Brain Sciences (2022-01-01)
    Get full text
    Article


  11. 11

    Changes Related to Age in Natural and Acquired Systemic Self-IgG Responses in Malaria by Romuald Dassé, Didier Lefranc, Sylvain Dubucquoi, Patricia Dussart, Virginie Dutoit-Lefevre, Boualem Sendid, François Sombo Mambo, Patrick Vermersch, Lionel Prin

    Get full text
    Article


  12. 12

    Impact of Natalizumab on Productivity and Ability to Work in Patients with Multiple Sclerosis in France: The TITAN Study by Patrick Vermersch, Arnaud Kwiatkowski, Jérôme de Sèze, Alain Créange, Nathalie Texier, Sophie Fantoni-Quinton, Marilyn Gros, Marta Ruiz, Christine Lebrun-Frenay, on behalf of the TITAN Investigators

    Published in Neurology and Therapy (2025-04-01)
    Get full text
    Article


  13. 13

    Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosis by Gavin Giovannoni, Enrique Alvarez, Ellen Tutton, Olaf Hoffmann, Yan Xu, Patrick Vermersch, Celia Oreja-Guevara, Maria Trojano, Ralf Gold, René Robles-Cedeño, Mudeer Khwaja, Bianca Stadler, Jo Vandercappellen, Tjalf Ziemssen

    Published in Digital Health (2023-05-01)
    Get full text
    Article


  14. 14

    Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial by Bruno Dubois, Jesús López‑Arrieta, Stanley Lipschitz, Triantafyllos Doskas, Luiza Spiru, Svitlana Moroz, Olena Venger, Patrick Vermersch, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Magda Tsolaki, for the AB09004 Study Group Investigators

    Published in Alzheimer’s Research & Therapy (2023-04-01)
    Get full text
    Article


  15. 15

    Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study by Klaus Schmierer, Heinz Wiendl, Frederik Barkhof, Xavier Montalban, Anat Achiron, Tobias Derfuss, Andrew Chan, Suzanne Hodgkinson, Alexandre Prat, Letizia Leocani, Finn Sellebjerg, Patrick Vermersch, Hulin Jin, Laura Sponton, Anita Chudecka, Lidia Gardner, Nicola De Stefano

    Get full text
    Article


  16. 16

    Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study by Heinz Wiendl, Frederik Barkhof, Xavier Montalban, Anat Achiron, Tobias Derfuss, Andrew Chan, Suzanne Hodgkinson, Alexandre Prat, Letizia Leocani, Klaus Schmierer, Finn Sellebjerg, Patrick Vermersch, Hulin Jin, Anita Chudecka, Andreas Kloetgen, Dongdong Lin, Lidia Gardner, Nicola De Stefano

    Published in Neurology and Therapy (2025-07-01)
    Get full text
    Article


  17. 17

    Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey by Tjalf Ziemssen, Gavin Giovannoni, Enrique Alvarez, Virender Bhan, Carrie Hersh, Olaf Hoffmann, Celia Oreja-Guevara, Rene R Robles-Cedeño, Maria Trojano, Patrick Vermersch, Pamela Dobay, Mudeer Khwaja, Bianca Stadler, Benedict Rauser, Thomas Hach, Daniela Piani-Meier, Jason Burton

    Published in Journal of Medical Internet Research (2021-10-01)
    Get full text
    Article


  18. 18

    Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review by Óscar Fernández, Óscar Fernández, Per Soelberg Sörensen, Per Soelberg Sörensen, Giancarlo Comi, Giancarlo Comi, Patrick Vermersch, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Letizia Leocani, Letizia Leocani, Thomas Berger, Thomas Berger, Bart Van Wijmeersch, Bart Van Wijmeersch, Celia Oreja-Guevara, Celia Oreja-Guevara

    Published in Frontiers in Immunology (2024-04-01)
    Get full text
    Article


  19. 19

    Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study by Heinz Wiendl, Frederik Barkhof, Frederik Barkhof, Xavier Montalban, Anat Achiron, Anat Achiron, Tobias Derfuss, Andrew Chan, Suzanne Hodgkinson, Alexandre Prat, Letizia Leocani, Letizia Leocani, Letizia Leocani, Klaus Schmierer, Klaus Schmierer, Finn Sellebjerg, Finn Sellebjerg, Patrick Vermersch, Hulin Jin, Anita Chudecka, Andreas Kloetgen, Dongdong Lin, Lidia Gardner, Nicola De Stefano

    Published in Frontiers in Immunology (2025-03-01)
    Get full text
    Article


  20. 20

    Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study by Heinz Wiendl, Frederik Barkhof, Frederik Barkhof, Xavier Montalban, Anat Achiron, Anat Achiron, Tobias Derfuss, Andrew Chan, Suzanne Hodgkinson, Alexandre Prat, Letizia Leocani, Letizia Leocani, Letizia Leocani, Klaus Schmierer, Klaus Schmierer, Finn Sellebjerg, Finn Sellebjerg, Patrick Vermersch, Hulin Jin, Anita Chudecka, Andreas Kloetgen, Dongdong Lin, Lidia Gardner, Nicola De Stefano

    Published in Frontiers in Immunology (2025-02-01)
    Get full text
    Article


Search Tools: